Circadian rhythm alterations have been implicated in multiple neuropsychiatric disorders, particularly those of sleep, addiction, anxiety, and mood. Circadian rhythms are known to be maintained by a set of classic clock genes that form complex mutual and self-regulatory loops. While many other genes showing rhythmic expression have been identified by genome-wide studies, their roles in circadian regulation remain largely unknown. In attempts to directly connect circadian rhythms with neuropsychiatric disorders, genetic studies have identifi ed gene mutations associated with several rare sleep disorders or sleep-related traits. Other than that, genetic studies of circadian genes in psychiatric disorders have had limited success. As an important mediator of environmental factors and regulators of circadian rhythms, the epigenetic system may hold the key to the etiology or pathology of psychiatric disorders, their subtypes or endophenotypes. Epigenomic regulation of the circadian system and the related changes have not been thoroughly explored in the context of neuropsychiatric disorders. We argue for systematic investigation of the circadian system, particularly epigenetic regulation, and its involvement in neuropsychiatric disorders to improve our understanding of human behavior and disease etiology.
Introduction
Circadian rhythms are endogenous biological cycles ~24 h in length. They are found in most living organisms, and can be adjusted by factors called zeitgebers, or "timegivers", including light [1] , temperature [2] , diet [3] , odor [4] , and gravity [5] , light being the dominant cue. Maintaining a rhythmic daily life is critical for surviving the recurrent environmental changes. These rhythms can be easily observed in behaviors such as sleeping and eating, but also, less visibly, affect crucial biological systems such as metabolism [6, 7] and the cardiovascular system [7] .
Multiple circadian rhythms throughout the rest of the brain [8] and the body [9] . At the same time, peripheral tissues, even cultured cells [10;11] have their own local, autonomous clocks that can be self-sustaining, but they may be synchronized by signals from the SCN [12] .
Clock genes underlying circadian rhythms can be casein kinase 1e, CSNK1E). These genes were mainly identified by the screening of mutants of fruit flies, mice, and hamsters [13] . These few CGs make up a group of auto- regulate through D-box promoters [14, 15] ; while the REV-ERB alpha and ROR family members bind to the REV-ERB/ROR response element (RRE) [16] . cAMP response elements (CREs) are also central regulatory motifs that mediate rhythmic expression [17] . These regulatory systems have been thoroughly reviewed [13, [18] [19] [20] .
In addition to CGs, hundreds of non-CG genes are transcribed rhythmically. They are part of the broadlydefi ned clock genes. In fact, one would expect that genes carrying E-box, D-box, RRE, and CRE promoters could be potential clock genes [21, 22] . Certainly, these genes could include both the drivers and passengers of a large circadian regulatory system, though most of the causeeffect relationships remain to be discovered. Increasing numbers of CGs have been identified through genomewide expression profiling studies, mostly in mice, as summarized in Table 1 . Just to name a few, 2%-10% of genes are expressed in a circadian manner in various mouse tissues [23] [24] [25] [26] [27] [28] ; in the mouse SCN, 337 genes were found to be expressed cyclically, and 335 were in the liver [26] . Another mouse study detected 575 genes in the liver and 462 in the heart with circadian expression [27] .
Human studies have also revealed time-dependent expression in blood and brain. A 2010 study on gene expression induced by food-intake identified expression changes associated with biopsy time for 8 197 genes in blood (false discovery rate (FDR) 2.6%) [29] . This is the largest human circadian study thus far, with 40 individuals sampled at 14 time-points each, for a total of 560 blood samples. In this study, Li et al. (2013) reported circadian expression in human postmortem brain. They used time of death to represent time-points in the 24-h cycle, turning individual differences into differences of expression at different time-points. They analyzed 12 000 transcripts in six brain areas (dorsolateral prefrontal cortex, anterior cingulate cortex, hippocampus, amygdala, nucleus [208] Human Skeletal muscle Expression Affymetrix U95a
Leonardson et al. 2010 [29] Human Blood Expression Custom array
Li et al. 2013 [30] [30] . Among the healthy controls, >417 transcripts in each region showed 24-h oscillation (nominal P <0.05), while 169 genes had an FDR of <0.5 for combined P values across regions. These 169
genes are considered to be common circadian genes in the brain [30] . Another study on human postmortem dorsolateral prefrontal cortex samples from 536 individuals used RNASeq and global statistics to show rhythmic expression without naming specifi c clock genes [31] .
Most of these cases of rhythmic expression are tissuespecific, suggesting tissue-specific regulatory network.
Only 28 cycling genes are shared between mouse SCN and liver [26] , while 37 are shared between mouse liver and heart [27] . Another analysis of 21 microarray data sets from 14 mouse tissues found that the expression of 41 out of 19 168 genes showed consistent circadian oscillation across multiple tissues [32] . This alerts us to the fact that studies of the circadian regulatory system should take tissue-specifi city into account.
It should be noted that the number of cyclicallyexpressed genes reported is related to the experimental design, statistical method, and signifi cance cutoff. With the liberal significance criteria (P <0.05) used in the human brain study by Li et al., some of the CGs still did not show rhythmicity [30] . However, these findings are not definitive, complexes are central to the control of circadian gene expression by environmental cues [32] . CHRONO [33, 34] and UBE3A [35] were found to be essential in regulating circadian rhythms in mice in three 2014 studies. Genes involving protein translation, including rRNA, also showed rhythmic expression [36] . Furthermore, an siRNA screen of a human osteosarcoma cell line, targeting 17 631 known and 4 837 predicted human genes, discovered ~343 clock genes or modulators [37] . These data suggest that the underlying organization of circadian rhythms has not yet been completely described.
Rhythmic expression is certainly not the only aspect of circadian rhythms. Protein abundance and posttranslational modifications, such as phosphorylation and ubiquitination, have also been shown to have daily oscillations in Neurospora crassa, the fruit fly, and multiple tissues in mouse, rat, and hamster, as reviewed by others [38] [39] [40] [41] . Similar circadian molecular mechanisms may exist in humans, but remain to be explored. From chromatin to transcripts, mRNA to proteins and to protein modifications, circadian rhythms encompass a complex regulatory system, including the epigenomic components discussed below.
Genetics of Sleep-Related Traits
While circadian patterns can be observed from the molecular level all the way up to the organismal behavior level, the sleep-wake cycle and other sleep-related traits are probably the most salient outputs of the circadian clocks. These traits are known to be heritable [44] , and the underlying genes can be identified directly by genetic methods using human population data, without relying on knowledge of specifi c clock genes. The heritability of sleep measures, including timing, duration, and quality, varies between 12.4% and 29.4% [42] . A study of 410 normal adults has identified a polymorphism in CLK associated with morningness-eveningness preferences [43] . Furthermore, in a GWAS of 4 251 individuals, Allebrandt et al. (2013) identified an intronic variant (rs11046205) in the ABCC9 gene associated with sleep duration (P = 3.99e-8) [44] .
On the other hand, the circadian system is not the only regulator of sleep. Energy homeostasis and its interactions with circadian rhythms also contribute to maintenance of the sleep-wake cycle [45, 46] . While homeostasis and other factors play signifi cant roles in sleep regulation, sleep has For example, manipulating the lighting environment and feeding pattern have been shown to induce circadian and related genomic and epigenomic changes [47] .
Circadian Disruptions Are Implicated in Neuropsychiatric Disorders
Disruption of circadian rhythms is associated with or implicated in many traits or diseases, including metabolic syndrome [48] , obesity [49] , diabetes [50] , infl ammatory diseases and autoimmune disorders [51] , cancer [52] , drug efficacy and toxicity [53] , cardiovascular disorders [54] , and mental disorders [55, 56] .
Among neuropsychiatric disorders, sleep-wake disorders, anxiety, mood disorders, and addiction have the Major evidence is summarized in Table 2 . A few examples of indirect evidence linking circadian rhythms to non-sleeprelated neuropsychiatric disorders are as follows: abnormal sleep is co-morbid with many disorders [57] . Persistent sleep disturbances have been found to increase the risk of developing anxiety [58] and depression [59;60] . Insomnia and substance abuse disorders promote the risk of each other [60, 61] . Melatonin is important in synchronizing circadian rhythms [62] , and agomelatine that targets the melatonergic system is an antidepressant [63] ; agomelatine has been shown to increase the relative amplitude of an individual's rest-activity cycles [64] . Ketamine, a drug with rapid-acting antidepressive effects, influences the recruitment of the CLK-BMAL1 complex to E-box promoters and alters the expression of CGs [65] . Another antidepressant, escitalopram, has been reported to restore the disrupted rhythmic expression of several CGs in a study of blood samples from 12 MDD patients and 12 controls [66] . Animal models with disrupted clock genes show behavioral changes similar to mood disorders [67] or schizophrenia [68] . Therefore, circadian rhythms have been of interest in the study of these disorders. However, the question of causation largely remains to be addressed.
A multi-system hypothesis has been formulated to explain the connections between circadian rhythm disturbance and addiction, as well as anxiety. Based on a literature review, Gorwood highlighted the cortisolmelatonin-vasopressin interaction for anxiety, as this interaction nicely bridges stress-response and circadian systems [69] . Drugs of abuse may infl uence the interwoven molecular networks of circadian rhythms, stress-response, reward circuitry, neuroplasticity and memory, and ultimately lead to the development of addiction, as well as withdrawal symptoms. The paraventricular nucleus in the hypothalamus has been proposed to be the location where circadian and stress signals converge, and where multiple clock genes, neuropeptides, and stress-response genes interact [70] . Such interactions between circadian systems and stress-response systems may play an important role in many psychiatric disorders, including but not limited to addiction [71] .
The dopamine D2 receptor (DRD2) is another interesting candidate linking the circadian system and the reward pathway, as it mediates the photic response to regulate circadian rhythms, and the most important reward pathway is dopaminergic [72] . Several candidate gene studies have found signifi cant associations between DRD2
variants and different kinds of addiction (alcohol, cocaine, heroin, and nicotine) [73, 74] . However, a meta-analysis [75] and [59, 60] . Abnormal Risk factor for developing anxiety [58] ; Bi-directional relationship:
comorbidity, or as circadian rhythms in hormone levels, body children daily regularity predicts addiction disrupts circadian a risk factor temperature, sleep, and behavioral patterns anxiety levels >10 years later [168] rhythms; sleep and mood reported in patients with MDD [162] [163] [164] ; degree problems increase chance of circadian misalignment correlated with of addiction [60;169] severity of depression [165] ; sleep disturbance in manic and depressive phases, even possibly euthymic phases [166, 167] .
Therapy Seasonal affective disorder (SAD) patients Agomelatine affects circadian respond to light therapy [170] ; sleep deprivation rhythms [64] , also effective in treating treats depression [171] ; sleep deprivation may anxiety disorders [176, 177] .
switch a depressed patient into hypomania or mania [172] ; agomelatine increases relative amplitude rest-activity cycles [64] ; lithium lengthens circadian period in hamsters [173] .
Chronotype Mood disorders associated with chronotype [178, 179] Evening chronotype associated with substance abuse [180;181] Social rhythms Disrupted social rhythms [182] [183] [184] Lower daily regularity in anxiety patients [185] Seasonal pattern Seasonal changes in bipolar disorder [186, 187] Case report of SAD with cyclical cocaine craving [188] Hormone Rhythmic melatonin level [189, 190] Cortisol level is rhythmic [191] Cortisol secretion patterns linked to addiction [192] Clock gene genetic 17 studies of candidate genes [193] One candidate gene study [194] Six genetic studies [195] [196] [197] [198] [199] [200] association Clock genes in Knockout of REV-ERB alpha increases Per1 and Per2 expression levels in 14 studies of Clock, per1, animal models midbrain dopamine production and induces nucleus accumbens regulate anxiety and per2 mutant mice mania-like behavior by regulating tyrosine levels in knockout mouse models and showed behavior changes hydroxylase gene expression in a mouse study [201] . mice experiencing chronic social defeat in response to drug [203] Clk mutant shows mania [67] stress [202] . Clk mutant less anxious [67] Clock gene expression Ketamine infl uences expression of clock genes [65] ; Anxiolytic medications reduce mPer1 Chronic methamphetamine in response to drug escitalopram restores disrupted rhythmic expression in mice [205] treatment desynchronizes treatment expression of several clock genes [66] ; lithium clock gene expression affects expression of multiple clock genes [174, 175, 204] ; between striatum and valproic acid changes phase and amplitude of SCN [206] ; ethanol and drugs PER2 expression in cultured cells [117] . of abuse alter clock gene expression in SCN and other brain regions [203] Clock gene expression Expression changes of clock genes in changes in patients MDD brain [30] and blood [207] .
Review
Gonzalez 2014 [193] Philip Gorwood, 2012 [69] Logan RW et al. 2014 [203] a GWAS [76] of alcoholism reported inconsistent results,
suggesting that the DRD2 contribution may be small, if at all. A DRD2 variant has also been reported to be associated with anxiety disorders with co-morbid alcoholuse disorder [77] . But the fi nding is also weak and requires replication.
Circadian Genetics of Neuropsychiatric Disorders
Genetic studies may capture direct evidence that specifi c 
Sleep-Wake Disorders
Sleep-wake disorders impair the quality of life, affect learning, memory, and mood. These disorders have a clear genetic basis. Family and twin studies of insomnia report heritability ranging between 21% and 58% [78] [79] [80] [see Palagini et al. (2014) for a thorough review [81] ]. Travel across time zones, sleep deprivation, and shiftwork all disturb sleep patterns. Insomnia, hypersomnia, and narcolepsy are major sleep-wake disorders [82] . Some of these are common, like insomnia (~10% of adults have severe insomnia that cause daytime consequences [83] ), and some are rare, like narcolepsy (affecting ~1 in 3 000) [84] .
Jet-lag and shiftwork-related sleep problems are common in specifi c occupations, like fl ight attendants, nurses, and soldiers.
Mutations in genes responsible for some specific, mostly rare forms of sleep disorders have been discovered.
A mutation (R192H) in GABRB3 has been found in patients with chronic insomnia. Since GABRB3 encodes a subunit of a chloride channel that serves as the receptor for gammaaminobutyric acid (GABA), a major inhibitory neurotransmitter of the mammalian nervous system, a decrease in GABAergic inhibition may contribute to insomnia [85] . Interestingly, hypersomnia was also recently linked to GABA(A) receptor regulation [86] . Another excessive sleeping disorder, narcolepsy, is mostly caused by a deficiency in hypocretin (HCRT), an excitatory neuropeptide [87] .
Mutations in PER2 and CSNK1D have been reported in Advanced Sleep Phase Syndrome (ASPS) patients. A rare autosomal dominant mutation of PER2 has been found to be responsible for ASPS in members of a Utah family [88] .
CKIdelta (CSNK1D) was found to have a missense mutation responsible for ASPS [89] .
Knockout or mutation of many other genes, including IA2 [90] , has been found to change sleep-related behaviors in mice, and has been reviewed elsewhere [91] . These genes could be candidates for human sleep disorders, but mutations have not been detected in humans so far.
The search for genes of the common forms of sleep disorders has produced positive and negative results. A GWAS of insomnia with 2 267 samples did not detect any significant genome-wide association [92] . [93] [94] [95] [96] and narcolepsy (TRA-alpha and TRAJ10) [97] .
It should be noted that a circadian defect is not the 
Non-Sleep-Related Neuropsychiatric Disorders
Genetic variants of candidate genes of CGs have been tested for association with bipolar disorder [98, 99] , depression [100] , seasonal affective disorder [101, 102] , or anxiety disorders [77] , alcohol use [103] , heroin addiction [104] , bipolar disorder and schizophrenia [105] , major depression and bipolar disorder [106] , and depression and sleep disorder [107] .
Though some positive associations were reported, most fi ndings were weak and not replicated. [108] . Bipolar disorder, schizophrenia, attention defi cit hyperactivity disorder, and MDD as a group of disorders and lithium-responsiveness have been shown
to have association signals enriched in 18 core clock genes and genes reported to be rhythmically expressed in more than six mouse tissues. This is the first GWAS evidence supporting potential genetic contributions of the circadian system to neuropsychiatric disorders, although the selection of clock genes in this study may be debatable and replication is warranted.
It is important to note that the CGs did not appear as any of the top GWAS signals of these psychiatric disorders, despite the fact that circadian disruption has been strongly implicated in such disorders. Genetic studies of depression, anxiety, and addiction have yielded largely negative results [109] [110] [111] [112] [113] . The study by McCarthy et al. 
Epigenetic Factors Regulate Circadian Rhythms
When genetics has had limited success in providing direct 
Acetylation and Deacetylation
The epigenetic mechanism that CLK uses to regulate circadian rhythms is histone acetylation and deacetylation. Etchegaray et al. (2003) showed in a mouse liver study that histone acetyltransferase (HAT) p300 works with the Clock/Bmal1 complex to regulate histone H3 acetylation at the promoters of the Cry and Per genes to influence their expression [114] . further showed that CLK itself possesses HAT activity, which can be enhanced by its partner BMAL1, when bound to E-box [115] . CLK is also involved in acetylating other non-histone substrates including BMAL1. Acetylated BMAL1 recruits CRY1 to the CLK-BMAL1 complex and represses transcription [116] .
Histone deacetylase (HDAC) has a function opposite to that of HAT, and is also an important regulator of circadian rhythms and memory formation, as well as metabolism. It removes acetyl groups from ε-N-acetyl lysine on histones, allowing the histones to wrap the DNA more tightly. The HDAC inhibitor valproic acid and trichostatin A were found to increase H3 acetylation and affect Per2 expression in an in vitro study [117] .
A mouse model has shown that Hdac3, one of the Hdac subtypes, is recruited by nuclear receptor corepressor 1 (Ncor1) and is involved in repressing Bmal1 expression, thus affecting circadian rhythms and metabolism [118] . Hdac3 recruitment also fl uctuates rhythmically in the mouse liver, in conjunction with Rev-erb-alpha and Ncor, to form a Hdac3/Rev-erb-alpha/Ncor complex [119] . It is to be expected that the transcription of many genes oscillate with the fl uctuation of HDAC3-related histone modifi cation, or RevErb-alpha/NCoR1-related signaling pathways.
Another member of the HDAC family, an NAD(+)-dependent protein deacetylase, SIRT1, also works directly with clock genes. SIRT1 binds CLK-BMAL1 and promotes deacetylation and degradation of the PER2 protein in mice [120] . SIRT1 is also a metabolic sensor, as it requires binding of its coenzyme NAD+ for its HDAC enzymatic activity. Thus, through SIRT1, metabolic states are linked to the circadian system. In addition, SIRT1 has been implicated in aging and neurodegeneration [121, 122] , synaptic plasticity, and memory formation in mouse studies [123, 124] .
The lysine-specific demethylase JumonjiC and ARID domain-containing histone lysine demethylase 1a are also major binding partners of CLK-BMAL1. This can inhibit HDAC1 function and enhance transcription by CLK-BMAL1
in a demethylase-independent manner. The CLK-BMAL1 complex plays a conserved circadian regulatory role across insect and mammalian species [125] .
DNA Methylation
The role of DNA methylation in circadian regulation is supported by a human study in which plasma homocysteine levels and the global DNA methylation level showed 24-h variation in the blood of 15 males and 15 females [126] .
Homocysteine level has been linked to DNA methylation in many studies [127] . An epigenome-wide study using methyl-DNA immunoprecipitation (MeDIP-chip) in mice showed that altered day-length changed gene expression profiles and promoter DNA methylation in the SCN, suggesting that DNA methylation regulates the circadian clock in the SCN [128] . Moreover, a study in mice showed that sleep deprivation can change the DNA methylation and hydroxymethylation of hundreds to thousands of CpG sites near genes involved in neuritogenesis and synaptic plasticity, the cytoskeleton, signaling, and neurotransmission [129] . Direct evidence supporting the roles of DNA methylation in regulating circadian rhythms came from a human study, which used global statistics to show evidence of signifi cant 24-h rhythmicity of DNA methylation, as well as its correlation with rhythmic gene expression in human dorsolateral prefrontal cortex [31] .
Non-coding RNA
MicroRNAs (miRNAs), probably the most intensively studied class of non-coding RNAs (ncRNAs) so far, may contribute to the regulation of circadian rhythms. Dicer is the major enzyme in miRNA biogenesis, and Dicer-defi cient mice and cells show shorter circadian cycles due to faster translation of PER1 and PER2 proteins. It has been
proposed that microRNAs miR-24, miR-29a, and miR-30a specifically target PER1 and PER2, thus determining the period of the cycle [130] .
Studies in mice have also implicated two other miRNAs, miR-134 and miR-132, in circadian regulation.
miR-134 is brain-specific, and regulated by SIRT1 [124] . It is involved in the regulation of CREB and BDNF levels,
proteins that are important in many neuronal functions and activities [124] . miR-132 is a direct link between light and chromatin remodeling: it is induced by photic entrainment cues via the mitogen-activated protein kinase (MAPK)-CREB signaling pathway [131] and regulates chromatin remodeling and translation [132] .
Other ncRNAs have strong potential in regulating circadian rhythms too. Rhythmic expression has been reported for 112 long non-coding RNAs (lncRNAs) in the rat pineal gland, which is the source of melatonin [133] , while melatonin is an important hormone timing circadian rhythms. A study of Neurospora gene frequency (frq) demonstrated that lncRNAs regulate circadian rhythms through anti-sense expression [134] . RNA-Seq of periodnull Drosophila has identifi ed several ncRNAs with diurnal expression, including a family of small nucleolar RNAs (snoRNAs) [135] . It should be noted that some ncRNAs, particularly lncRNAs, evolved fast and are speciesspecifi c [136, 137] . These fi ndings in non-humans only suggest possible epigenetic mechanisms that may occur in humans.
The actual genes in humans remain to be discovered.
RNA Modifi cation
Post-transcriptional RNA processing and modifi cation may be relevant to clock function. A recent study in mice and cultured human cells showed that n 6 -methyladenosine RNA-methylation, one of the most common RNA modifi cations, is involved in circadian clock regulation [138] .
Studies have also shown that diet affects the epigenetic regulation of circadian function. In a study of Japanese reversed by postnatal diet [139] . Exposure to different lengths of light per day changes the SCN and neuronal Per1 gene expression and behavior after birth in mice [140] , suggesting possible epigenetic modifi cation induced by early-life environmental effects, although epigenetics was not part of the study.
The epigenetics of circadian systems is a new, emerging research field, leaving a lot to be investigated.
Most studies have been performed in mouse models,
and only a few in humans. Since differences in epigenetic regulation between mice and humans during preimplantation development have been reported [141] , fi ndings from mice and other species may not translate to humans It is not known whether these factors work independently or interactively to regulate each of the clock genes, or the circadian system as a whole, and how. For these reasons, we advocate a more comprehensive epigenomic study of the circadian system in humans.
Circadian Epigenetics in Neuropsychiatric Disorders
Although plenty of data have implicated circadian rhythms in the risk of neuropsychiatric disorders, and that epigenetic factors are important regulators of these rhythms, only very limited studies have been performed to explore the epigenetics changes in neuropsychiatric disorders. number of genes with a circadian expression profile was also reduced from 1 855 to 1 481 [142] . This same research group also studied the blood transcriptome in desynchrony of sleep-wake timing and circadian rhythms, and identifi ed a dramatic reduction of rhythmic transcripts (6.4% to 1.0%) caused by desynchrony [143] . The chromatin modification and expression regulation pathways were consistently implicated by the differentially-expressed genes in these two sleep studies.
Sleep-Related Disorders
Bollatti et al. (2010) studied the effects of daytime and nighttime shiftwork on global DNA methylation and the methylation of the promoters of three candidate genes (glucocorticoid receptor, tumor necrosis factor alpha (TNF-α), and interferon-gamma) using peripheral blood DNA from 100 shift-workers and 50 day-workers in Northern
Italy. A small but significant difference in methylation was detected between morning and evening type shiftworkers in the TNF-α promoter. However, no significant methylation difference was detected when comparing shiftworkers to day-workers [144] . It is notable that all the reported associations or correlations were weak.
Non-Sleep-Related Neuropsychiatric Disorders
Prader-Willi syndrome (PWS) is the first neuropsychiatry disorder with evidence of disrupted circadian epigenomics.
PWS is a genetic disorder featuring obesity, intellectual disability, and sleep abnormalities. This disorder is frequently co-morbid with psychiatric problems [145] . It is caused by a deletion on the paternal chromosome 15q11-q13, considered to be caused by loss of snoRNAs [146] , which are processed products of a lncRNA gene, 116HG. A study of mice lacking 116HG showed altered expression of several clock genes and energy use in the brain [147] .
Another pilot study connecting the genetics and epigenetics of clock genes to psychiatric disorders is on miRNA. The precursor of miR-182 was found to carry an SNP rs76481776 that is associated with late insomnia in MDD patients (corrected P <0.00625), in a study of 359 MDD patients and 341 control individuals. CLK is one predicted target of miR-182 and the regulatory relationship was validated by in vitro assays [148] . This relationship between an SNP, the expression of an miRNA, and its targets warrants further investigation. However, it does suggest that we should pay more attention to subtypes or endophenotypes rather than diagnostic classifi cation, when studying the genetics and epigenetics of those disorders.
Clearly, circadian epigenomics has not received sufficient attention in the study of neuropsychiatric disorders although the circadian rhythms have been one of the major phenotypes to study in these disorders.
Future Perspectives
Based on the studies reviewed above, we see that Understanding the complex biological systems that produce them is necessary to decipher complex traits such as neuropsychiatric disorders [149] . Circadian regulation is a complex biological system. Environmental factors and internal biological infrastructure work together: light acting through photoreceptors, food working through SIRT1-related pathways, and psychological stress through the hypothalamo-pituitary-adrenal neuroendocrine system, all of which regulate an organism's internal clock. Serotonergic, dopaminergic, and maybe other neurotransmitter systems interact with circadian regulatory networks to influence human behavior and disorders.
Our current knowledge about circadian rhythms is largely derived from studies of candidate genes, their biochemistry, genomics, and epigenomic regulation.
There are very limited genome-wide, systematic studies in humans (Table 1) . Genome-wide studies are critical for obtaining an unbiased understanding of biological systems.
It is important to put existing knowledge into a biological network, to re-assess all the interactions and signaling connections. Novel components of circadian controls, from environmental cues to the downstream effectors, will be discovered. Several papers have advocated the use of systems biology to study circadian rhythms, and to construct the regulatory system of circadian rhythms through integration of multiple -omics [150] [151] [152] .
A complete circadian regulation system should contain every member of the circadian regulation cascades, from be much easier to use drugs to modify the epigenome than to correct mutated genes.
Understanding the genetics and epigenetics of circadian-related traits and diseases will lead to better and more precise diagnosis of circadian-related disorders.
Ultimately, this will improve the quality of life for people suffering from disorders due to jet-lag or shift-work, when
we are able to develop epigenetic interventions to ease the pains and discomfort.
Through our review, it is clear that epigenetics may play important roles in regulating circadian rhythms and associated neuropsychiatric disorders, but related studies are lacking today. The circadian cycle is a highly environment-dependent biological process. The circadian cycle is one of the best models to study environmental impact and gene-environment interactions. Much effort should be placed on this interesting research fi eld. Using circadian-related phenotypes and biomarkers, we may have an exceptional opportunity to access the dark kernel of psychiatric disorders.
